Insight Pharma Reports Releases “Next-Gen Seq Spurs Personalized Mitochondrial Medicine" Interview

Jan. 20, 2011 - PRLog -- Needham, MA - Insight Pharma Reports announces the release of a complimentary interview transcript now available for download: “Next-Generation Sequencing Spurs Personalized Medicine” with Steve S. Sommer, MD, PhD, Founder and President, MEDomics.

This complimentary interview transcript is available to download at http://www.InsightPharmaReports.com

The interview transcript is included in the CHI Insight Pharma Report titled “Next-Generation Sequencing Technologies: Applications and Markets.”  Following an overview of the evolution of NGS, the report turns to an examination of NGS applications in basic and applied research. A great deal of NGS effort today centers on cancer, but other basic research areas stand to benefit as well (e.g., immunogenetic studies, neurological and psychiatric diseases, infectious diseases, metagenomics, evolution). NGS has empowered the growth of epigenomics; several approaches exist, but bisulfite-enabled Methyl-seq currently dominates the scene.

For full report details and to order this report, visit: http://www.insightpharmareports.com/reports_report.aspx?r...

Organizations interested in receiving more information on CHI’s Insight Pharma Reports or for details on multi-user licenses and corporate subscriptions should contact Jack Valeri at 781.972.1355 or jvaleri@healthtech.com

Contact:
James Prudhomme
Marketing Manager
Cambridge Healthtech Institute
781.972.5486
jprudhomme@healthtech.com

# # #

Insight Pharma Reports are written by experts in consulting and industry who collaborate with us to provide a series of reports that evaluate the salient issues in pharmaceutical technology, business, and therapy markets. Insight Pharma Reports is a division of Cambridge Healthtech Institute.